Why and How Imprinted Genes Drive Fetal Programming by Crespi, Bernard J.
PERSPECTIVE
published: 24 January 2020
doi: 10.3389/fendo.2019.00940







Harvard University, United States







This article was submitted to
Pediatric Endocrinology,
a section of the journal
Frontiers in Endocrinology
Received: 27 November 2019
Accepted: 27 December 2019
Published: 24 January 2020
Citation:
Crespi BJ (2020) Why and How




Why and How Imprinted Genes Drive
Fetal Programming
Bernard J. Crespi*
Department of Biological Sciences and Human Evolutionary Studies Program, Simon Fraser University, Burnaby, BC, Canada
Imprinted genes mediate fetal and childhood growth and development, and early
growth patterns drive fetal programming effects. However, predictions and evidence
from the kinship theory of imprinting have yet to be directly integrated with data on
fetal programming and risks of metabolic disease. I first define paternal-gene and
maternal-gene optima with regard to early human growth and development. Next, I
review salient evidence with regard to imprinted gene effects on birth weight, body
composition, trajectories of feeding and growth, and timing of developmental stages, to
evaluate why and how imprinted gene expression influences risks of metabolic disease in
later life. I find that metabolic disease risks derive primarily frommaternal gene biases that
lead to reduced placental efficacy, low birth weight, low relative muscle mass, high relative
white fat, increased abdominal adiposity, reduced pancreatic β-cell mass that promotes
insulin resistance, reduced appetite and infant sucking efficacy, catch-up fat deposition
from family foods after weaning, and early puberty. Paternal gene biases, by contrast,
may contribute to metabolic disease via lower rates of brown fat thermiogenesis,
and through favoring more rapid postnatal catch-up growth after intrauterine growth
restriction from environmental causes. These disease risks can be alleviated through
dietary and pharmacological alterations that selectively target imprinted gene expression
and relevant metabolic pathways. The kinship theory of imprinting, and mother-offspring
conflict more generally, provide a clear predictive framework for guiding future research
on fetal programming and metabolic disease.
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INTRODUCTION
The deleterious effects of metabolic syndrome, comprising some combination of central obesity,
insulin resistance, hypertension, and dyslipidemia, represent a primary health challenge of our
generation (1). The majority of research on these problems addresses the “how” questions of
proximate, mechanistic causation, and treatment. A complementary question, and one that can
directly guide such work, is the ultimate, evolutionary question of why humans are so vulnerable to
this particular suite of diseases, with this set of manifestations.
Addressing the evolutionary causes of human disease risks requires analysis of human-specific
adaptations salient to growth, early development, and metabolism (2–4). Such adaptations center
on selection for maximization of inclusive fitness, in the context of social resource-related
interactions with other humans.
For the fetus, infant, and child, interactions with the mother guide development. These
interactions involvemixtures of cooperation and conflict, becausemothers and offspring are related
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by only one half (for most autosomal genes), leading to
selection for offspring to solicit more fitness-related resource
from the mother than she is selected to provide (5). Relatedness
asymmetries are higher still for imprinted genes, such that
paternally expressed alleles in offspring are predicted, under
the kinship theory of imprinting, to exert even more “selfish”
solicitation; maternally expressed imprinted genes in offspring by
contrast, are predicted to constrain such increased demand (6, 7).
Mother-offspring and paternal-maternal gene conflicts typically
generate molecular level tugs-of-war that lead either to dynamic
equilibria, or to one party “winning,” more or less (8–10).
The functional haploidy, conflictual dynamics, dosage
sensitivity, and direct links to fitness variation of imprinted genes
make changes in their expression an important cause of human
disease risks, especially through impacts on offspring growth
and development (2, 11). These health-related considerations
dovetail directly with fetal programming effects, which are
predominantly disease-related sequelae of growth patterns
during fetal and childhood development (12). Despite the large
body of previous work on fetal programming, no previous studies
have used the kinship theory of imprinting as a framework for
understanding fetal programming and its connections with
metabolic disease.
In this Perspective article, I evaluate the roles of genomic
imprinting in fetal programming of metabolic disease, from
theory to evidence. I first describe relevant background
concerning genomic imprinting effects in the context of
human development. I then describe three domains of
evidence showing how, and why, genomic imprinting drives
fetal programming.
ADAPTIVE AND CONFLICTUAL HUMAN
DEVELOPMENT
Humans develop through the fetal-placental stage, infant growth,
and differentiation fueled by breast milk, early weaning (for
an ape) facilitated by complementary feeding (baby foods) in
childhood, and juvenile and adolescent stages, when food is
obtained from the family, local group, and oneself (2, 11, 13, 14).
Under the kinship theory of imprinting, we can define relative
paternal-gene and maternal-gene optima for each stage of
development. These relative optima define axes of genomic
conflict, and axes of potential maladaptation in disease due to
dysregulation. The optima are relative, rather than absolute,
because, from theory and evidence, the paternal and maternal
imprinted genes are engaged in physiological “tugs” or “webs”
of war, with each party “pulling” in the context of the other
party “pulling back” in dynamic equilibrium. Losses of “pull”
on either side will thus lead to maladaptation for both parties
rather than optimality for one (15). This maladaptation is
directly reflected in the syndromic disorders caused by major
germline, chromosomal or epigenetic disruptions to imprinted
genes, that indicate the “pull points” of imprinted gene effects:
the set of traits that reflect effects of maternal or paternal pull
unopposed [e.g., (2, 6, 15)]. Typical development is expected
to manifest in some level of demand intermediate between
the maternal and paternal optima, with mothers, offspring,
and paternal genes and maternal genes in offspring, being
subject to deviations from their inclusive fitness optima to
some degree.
Placental development is driven by paternal gene expression,
constrained by maternal genes (12, 16–18). Optimal placentation
for paternal genes involves successful modification of maternal
spiral arteries, and a relatively effective placenta that directly
reflects the anatomical basis of fetal demand for maternal
resources. A well-developed placenta leads to an optimally large
baby, as regards parturition success, optimal birth weight and
body length, and an optimal body composition, where “optimal”
refers to expected effects on inclusive fitness of the offspring,
in comparison to inclusive fitness of the mother. Optimal body
composition will involve relatively high lean mass including
bodily organs, bone, and muscle (the “lean-mass working parts”
of the body). This set of traits corresponds closely with the
concept of “metabolic capacity” described by Wells (1, 19, 20):
the engine that powers human physiological, psychological, and
mechanical systems.
Optimal post-natal development for paternal genes engenders
vigorous and frequent sucking and rapid early growth (when
growth is food-limited rather than hormone-regulated, and
involves growth in lean mass as well as fat), delayed weaning,
enhanced solicitation of both complementary foods and later,
other-provided “family” foods (in comparison to self-feeding),
and delayed puberty that lengthens the overall period of
dependence (11, 14, 21, 22).
Optimal offspring growth and development for maternal
genes involves the relative opposite of the phenotypes above:
reduced (though “adequate”) placentation, smaller birth weight
and length, reduced lean mass and subcutaneous fat, and
so on. As regards body composition at birth, the maternal
optimum should involve reduced relative investment in lean
mass (especially muscle, pancreas, kidneys, bone, and liver)
to help spare energy for the brain and allow for relatively
increased abdominal white fat accumulation, partially in the
context of surviving infection and periods of restricted food in
infancy and childhood (23). Maternal genes are also expected
to favor relatively high levels of brown adipose tissue in infants
(which comprises about 10% of birth weight) (24), because it
generates high levels of heat that can contribute to the energy
budget of the mother, at some cost to the child. This apparent
maternal-gene effect on human infant thermiogenesis is directly
comparable to increased heat contributions caused by maternal
gene expression biases in the communal huddling of offspring,
among rodents (25).
Maternal gene optima also involve postnatal growth that
does not involve statural “catch-up” during early infancy, which
is energetically costly via lactation. Such offspring are instead
expected to put on relatively more fat (white adipose tissue)
in infancy and childhood, as a low-metabolic rate store of
food; they are also expected to reduce and delay acceptance of
complementary foods (which are also costly to mothers), instead
transitioning relatively early to self-foraging and self-feeding
(6, 22). Overall, these maternal-gene optima reflect the maternal
energetic tradeoff between investment in current vs. future
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offspring, whereby the inclusive fitness of mothers is maximized
by producing more offspring but investing less in each.
Maternal and paternal imprinted genes in offspring mediate
levels and patterns of demand for resources imposed upon
mothers, from conception until independence. Supply of
resources from the mother depends, in turn, on her ability to
meet demand, which is some function of her internal physical,
physiological, and psychological state, and external, ecological
conditions that may constrain resources available; for example,
shorter mothers have notably lighter babies (26), and food
restriction in the latter two trimesters of gestation causes low
birth weights [e.g., (27)]. Such limitations, as well as imprinted
gene effects and other genetic effects, activate the “fetal programs”
that reallocate available developmental resources to different
structures and functions, via a hierarchical, cascading series of
tradeoffs (3, 4, 28, 29). Most generally, fetal programs themselves
can be considered as reaction norms subject to effects of conflicts,
with distinct maternal gene vs. paternal gene inclusive fitness
optima for fetally programmed trajectories of cell and tissue
investment. How, then, are imprinted genes, and phenotypic axes
of imprinted-gene actions, related to fetal programs and their
effects on human health in childhood and later life?
THREE DOMAINS OF ASSOCIATION
BETWEEN FETAL PROGRAMMING AND
GENOMIC IMPRINTING
Fetal programming is linked with genomic imprinting effects
because both are determined by resource provision and
restriction in early development. As such, variation in imprinted
gene expression, and the differing optimal fetal program
trajectories of paternal vs. maternal genes, are predicted to
represent major determinants of advantageous and deleterious
programming effects, especially those that involve insulin
resistance, visceral obesity, and other manifestations of the
metabolic syndrome. This supposition is supported most directly
by the high frequency of imprinted genes among the top risk
factors and causes of type 2 diabetes and obesity [e.g., (30, 31)].
I describe below three major connections of genomic
imprinting with the causes and effects of fetal programming, with
emphasis on the links of theory with evidence across proximate
and ultimate domains of research. Figure 1 summarizes the
primary impacts of imprinted genes on fetal programming
effects, as described from previous studies.
Birth Weight
Weight at birth integrates effects of placental and fetal
development as regards resource demand and restriction. It
represents the major correlate of adverse fetal programming
effects on health, since the first studies by David Barker back in
the 1980s. Birth weight is also strongly influenced by expression
of imprinted genes, from analyses of large-scale naturally-
occurring loss and gains of imprinting (32, 33), studies of
SNPs, methylation and expression levels of imprinted genes [e.g.,
(34, 35)] and GWAS meta-analysis of birth weight [e.g., (36)];
for example, St. Pierre et al. (37) found that 31% of human
birth weight variance could be accounted for by genetic and
epigenetic variation at the IGF2/H19 locus. These studies support
the kinship theory prediction that higher birth weight should be
associated with biases toward paternal gene expression; in turn,
FIGURE 1 | The connections between genomic imprinting, fetal programming, and risks of metabolic syndrome.
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lower birth weight is associated with biases toward maternal gene
expression and its fetally programmed sequelae.
Beaumont et al. (38) showed that genes with strong GWAS
effects on birth weight (including the imprinted INS-IGF2 locus)
mediate risk of type 2 diabetes, thus providing clear evidence
of pleiotropy and a genetic basis to fetal programming effects.
One of the primary means to analyze the role of imprinted
genes in future work on fetal programming effects would be
to test effects of specific imprinted SNPs and transcripts on
both fetal, infant, and childhood traits including birth weight
and composition, and adult traits associated with the metabolic
syndrome. This has yet to be done. Prospective, longitudinal
studies of individuals with imprinted gene disorders are also
required, that can link gene expression and birth phenotypes with
later metabolic syndrome effects.
Body Composition
Bodies can be partitioned into fat mass vs. lean mass (mainly
skeletal muscle, bone, and internal organs), and brown fat (for
thermiogenesis) vs. white fat (in labile abdominal stores for
energetic reserve), among other bodily components.
Studies of imprinted gene alteration, and SNP variation
effects, indicate that biases toward paternal imprinted gene
expression favor increased skeletal muscle mass, bone mass,
and pancreatic β-cell mass, and reduced white fat mass [e.g.,
(31, 39–48)]. This paternal-gene tissue allocation pattern involves
high demands on the mother for the protein, fat, minerals,
and carbohydrates that lead to extensive insulin-fueled growth
in lean mass, which is expected to benefit offspring inclusive
fitness through large overall size, better physiological function,
better early survival, and higher reproduction [e.g., (1, 11)].
Enhancements to metabolic health are expected to follow most
directly from large skeletal muscle mass, and pancreatic β-cell
mass (leading tomore effective glucosemetabolism), and reduced
abdominal fat deposition (leading to reduced susceptibility to
other dimensions of metabolic syndrome).
The optimal maternal-gene tissue-allocation pattern involves,
conversely to the paternal one, lower lean mass, notably less
skeletal muscle and a smaller β-cell mass, and higher levels of
white fat, expressed mainly in abdominal white adipose tissue.
This pattern of allocation takes place in the context of reduced
overall resources (and lower birth weight), and appears to reflect
tradeoffs that alleviate some of the deleterious effects of small
body size, especially low early-life survivorship (19, 20, 49–55).
Thus, less skeletal muscle and a smaller β-cell mass promote
insulin resistance that can enhance survival and protect the brain
during periods of starvation or infection, and white abdominal
fat serves, in turn, as an energy reservoir, linked tightly with the
immune system, for fighting infectious disease (23, 56–58).
This set of conditional, best-of-bad-job adaptations (28) in
babies born small, and/or subject to maternal-gene biases, is
attuned to premodern environments of relative resource scarcity.
In current, novel environments with food available ad libitum,
this programmed system generates mismatch, promoting type 2
diabetes, abdominal obesity, and other effects of the metabolic
syndrome (Figure 1). The most severe metabolic syndrome
effects are found when light, skinny neonates exhibit extensive
catch-up growth after about 1 year of age, and are subject
to high levels of nutrition during later development and
adulthood [e.g., (1, 49, 59–61)].
Phenotypes optimal for maternal genes need not, and do
not, align exactly with deleterious fetal programming effects.
Thus, an important bodily tissue allocation trait favored by
maternally expressed imprinted genes is higher levels of brown
adipose tissue, which undergo energy intensive thermiogenesis.
In humans and/or mice, higher expression of the maternally
expressed genes CDKN1C and H19, and lower levels of the
paternally expressed genes DLK1, NDN, and XLas, promote
increased non-shivering thermiogenesis of neonates (25, 62–
64), which in mice benefits maternal genes in the context of
offspring cooperative huddling (25), and in humans should
benefit the mother energetically (65). Extension of high brown fat
thermiogenesis and high metabolic rate throughout childhood,
and into the adult stage, can prevent the development of
diet- and age-induced obesity (66), as evidenced, for example,
by the general lack of catch-up growth, obesity, or metabolic
syndrome in Silver-Russell syndrome, and the high energy
expenditure and lean phenotypes associated with loss of XLαs
expression (in contrast to low energy expenditure, obesity, and
insulin resistance, with reduced expression of Gsα) (18, 39).
Manipulation of imprinted gene systems affecting thermiogenesis
and metabolic rate offers exciting opportunities for therapeutic
alleviation of metabolic syndrome. Elucidation of the adaptive
significance of such effects in humans, in the context of
the kinship theory, requires further study of the roles of
thermiogenesis in the energetics of mother-infant interactions,
especially given the life-history differences between humans
and mice.
Trajectories of Post-natal Feeding, Growth
and Development
Lui et al. (67) and Finkielstain et al. (68) showed that post-
natal growth acceleration and deceleration are mediated by
expression of a suite of imprinted genes. Among infants, appetite
and sucking ability are increased by higher paternal imprinted
gene expression, with the clearest evidence from paternal gene
knockouts in mice and humans that reduce sucking [e.g., (11,
35, 69)]. For offspring born below optimal weight, paternally
expressed genes are expected to favor rapid early catch-up
growth, especially via lactation (with high costs to the mother),
and especially when growth in lean mass is still mediated by
insulin and IGF2 (11), although catch-up at any point may be
expected if it involves increased demands on themother. As such,
postnatal paternally biased gene expression effects that follow
environmentally induced intrauterine growth restriction may be
an important cause of catch-up growth and metabolic disease.
Maternal imprinted gene expression, by contrast, should favor
catch-up growth only after weaning (relative to before weaning),
and only when it involves modes of feeding with relatively
low costs to mothers; this later catch-up growth predominantly
involves white, abdominal adipose tissue. For example, deletions
of the paternally-expressed genes PEG3, DLK1, MAGEL2, and
NNAT (leading to maternal gene biases and poor early feeding)
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result in catch-up white fat, and are associated with adult
obesity (35, 70).
In humans, lactation is normally supplemented by feeding
of ’baby foods’ (so-called “complementary” foods) (13, 71)
some months after birth. Individuals with Angelman syndrome,
involving a paternal gene bias, show evidence of ‘picky’ eating
with preference for such foods, which are costly to mothers to
acquire and process (22). By contrast, individuals with Prader-
Willi syndrome, involving a maternal-gene bias, show highly
indiscriminate food choice and high rates of self-foraging, in
association with hyperphagia. Haig andWharton (72) interpreted
these latter findings in terms of reduced feeding demand being
imposed on mothers by children with Prader-Willi syndrome,
after weaning. Hyperphagia after weaning, which is also found
in mice with deletions of the paternally expressed gene Nnat
(35), will notably exacerbate fetal programming effects, especially
given that it follows prenatal and early postnatal restrictions
on growth.
Finally, theory and evidence indicate that maternally
expressed imprinted genes favor fast childhood development
and early menarche, which reduce demands on the mother
(21). In turn, early menarche is associated with higher risk of
metabolic syndrome later in life [e.g., (73)]. These considerations
of timing emphasize the benefits of early-infancy catch-up
in lean mass under paternal gene effects, compared to the
long-term metabolic costs of later, maternal-gene mediated,
catch-up fat.
CONCLUSIONS
Conflicts in biology are all about control of fitness-related
resources. Genomic imprinting thus originated and evolves
in the context of gene expression that controls levels and
patterns of resource demand, by offspring, for maternal
investments. This is ultimately why genomic imprinting
drives fetal programming. Proximately, the causal devils
are in the molecular details, that are explicable only in
terms of opposing, distinct inclusive fitness optima, some
of which also mediate variation in human health and risks
of disease.
An evolutionary-medical approach to understanding
metabolic syndrome requires integration of evolutionary
biology, for the study of tradeoffs, genomic conflicts, and
mismatches, with genetic, developmental, and physiological
data on mechanisms. The perspective provided here indicates
that maternal imprinted-gene phenotypic optima parallel
the deleterious fetal programming effects of early growth
restriction, though with important exceptions. These
findings provide insights into potential new therapies and
preventatives via manipulation of imprinted gene expression
and effects, and patterns of feeding, that should encourage
studies of fetal programming that test hypotheses inspired by
evolutionary theory.
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